Skip to content

Clinical trials

Completed Observational Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Observational Status: Completed Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20061
20071
20081
20106
20113
20133
20142
20171
20183
20206
20213
20223
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)7
Boehringer Ingelheim2
National Human Genome Research Institute (NHGRI)2
National Jewish Health2
University Medical Center Groningen2
University of California, San Francisco2
23andMe, Inc.1
Beijing Chao Yang Hospital1
Columbia University1
Creative Biosciences (Guangzhou) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis45
Lung Diseases, Interstitial10
Idiopathic Pulmonary Fibrosis8
Lung Diseases6
Pulmonary Disease, Chronic Obstructive6
Asthma3
Emphysema3
Pneumonia3
Sarcoidosis3
Adenocarcinoma2

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.